1-[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-[4-[[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-carbamimidamido-1,3,5-triazin-2-yl]amino]anilino]-1,3,5-triazin-2-yl]guanidine;2,2,2-trifluoroacetic acid结构式
|
常用名 | 1-[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-[4-[[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-carbamimidamido-1,3,5-triazin-2-yl]amino]anilino]-1,3,5-triazin-2-yl]guanidine;2,2,2-trifluoroacetic acid | 英文名 | 1-[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-[4-[[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-carbamimidamido-1,3,5-triazin-2-yl]amino]anilino]-1,3,5-triazin-2-yl]guanidine;2,2,2-trifluoroacetic acid |
|---|---|---|---|---|
| CAS号 | 2148282-47-5 | 分子量 | 914.8 | |
| 密度 | N/A | 沸点 | N/A | |
| 分子式 | C32H40F6N20O6 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | N/A |
| 英文名 | 1-[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-[4-[[4-(2-amino-4-butyl-5-oxo-4H-imidazol-3-yl)-6-carbamimidamido-1,3,5-triazin-2-yl]amino]anilino]-1,3,5-triazin-2-yl]guanidine;2,2,2-trifluoroacetic acid |
|---|
| 分子式 | C32H40F6N20O6 |
|---|---|
| 分子量 | 914.8 |
| InChIKey | OTIMERILYXPPHI-UHFFFAOYSA-N |
| SMILES | CCCCC1C(=O)N=C(N)N1c1nc(NC(=N)N)nc(Nc2ccc(Nc3nc(NC(=N)N)nc(N4C(N)=NC(=O)C4CCCC)n3)cc2)n1.O=C(O)C(F)(F)F.O=C(O)C(F)(F)F |
|
实验名称:In vivo agonist activity at NPR-A in iv dosed Crl:CD(SD) rat assessed as increase in ...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL3994006
|
|
实验名称:In vivo agonist activity at NPR-A in Crl:CD(SD) rat assessed as increase in cGMP accu...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL3994005
|
|
实验名称:Diuretic activity in iv dosed Crl:CD(SD) rat assessed as increase in urine volume adm...
来源:ChEMBL
靶标:Rattus norvegicus
External Id:CHEMBL3994002
|